Concepedia

Beate Schultheis

BS

52

Publications

5.3K

Citations

35

H-Index

1993

Active since

Affiliations

Heidelberg University(Current)

University Hospital Heidelberg

Universitätsklinik Marien Hospital Herne

Ruhr University Bochum

University Medical Centre Mannheim

Beate Schultheis is an author at Heidelberg University specializing in medicine, radiation oncology, and oncology.

Top concepts

Publications per year

1993–2020

52

Publications

52

Selection and characterization of BCR-ABL positive cell lines with differential sensitivity to the tyrosine kinase inhibitor STI571: diverse mechanisms of resistance

François Xavier Mahon, Michael W. Deininger, Beate Schultheis et al. · Blood · 2000 · 758 citations

Response to Imatinib Mesylate in Patients with Chronic Myeloproliferative Diseases with Rearrangements of the Platelet-Derived Growth Factor Receptor Beta

Jane F. Apperley, Martine Gardembas, Junia V. Melo et al. · New England Journal of Medicine · 2002 · 630 citations · Full text

Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+ cells

Letizia Venturini, Karin Battmer, M. Castoldi et al. · Blood · 2007 · 354 citations · Full text

Regorafenib (BAY 73-4506) in advanced colorectal cancer: a phase I study

Dirk Strumberg, M. E. Scheulen, Beate Schultheis et al. · British Journal of Cancer · 2012 · 252 citations · Full text

First-in-Human Phase I Study of the Liposomal RNA Interference Therapeutic Atu027 in Patients With Advanced Solid Tumors

Beate Schultheis, Dirk Strumberg, Ansgar Santel et al. · Journal of Clinical Oncology · 2014 · 250 citations

Rows per page

1–5 of 52